We are live on ! Find out more
BIA

Biondo Investment Advisors Portfolio holdings

AUM $780M
1-Year Est. Return 21.03%
This Fund
S&P 500
This Quarter Est. Return
+14.25%
1 Year Est. Return
+21.03%
3 Year Est. Return
+89.14%
5 Year Est. Return
+116.93%
10 Year Est. Return
+716.37%
AUM
$421M
AUM Growth
+$24.5M
Cap. Flow
-$21.7M
Cap. Flow %
-5.15%
Top 10 Hldgs %
54.25%
Holding
87
New
6
Increased
51
Reduced
19
Closed
7

Sector Composition

Rank Sector Weight
1 Healthcare 41.18%
2 Financials 13.34%
3 Technology 13.1%
4 Consumer Discretionary 7.56%
5 Communication Services 5.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ISRG icon
1
Intuitive Surgical
ISRG
$121B
$43.5M 10.33%
227,346
+3,213
+1% +$571K
MA icon
2
Mastercard
MA
$477B
$38.4M 9.11%
172,293
-2,525
-1% -$527K
AAPL icon
3
Apple
AAPL
$4.89T
$29.9M 7.09%
529,296
+15,200
+3% +$792K
ABMD
4
DELISTED
Abiomed Inc
ABMD
$29.3M 6.96%
65,149
-4,102
-6% -$1.62M
ILMN icon
5
Illumina
ILMN
$29.4B
$19.6M 4.65%
54,801
+3,686
+7% +$1.18M
IDXX icon
6
Idexx Laboratories
IDXX
$42.9B
$16.2M 3.84%
64,706
-1,090
-2% -$265K
GOOGL icon
7
Alphabet (Google) Class A
GOOGL
$3.91T
$15.1M 3.59%
250,320
-1,700
-0.7% -$103K
XYZ
8
Block Inc
XYZ
$45.9B
$13.9M 3.31%
140,680
+7,135
+5% +$550K
EXAS
9
DELISTED
Exact Sciences
EXAS
$12.1M 2.88%
153,710
+41,965
+38% +$2.74M
JPM icon
10
JPMorgan Chase
JPM
$939B
$10.5M 2.5%
93,195
+2,172
+2% +$247K
REGN icon
11
Regeneron Pharmaceuticals
REGN
$68.8B
$10.5M 2.49%
25,912
+9,070
+54% +$3.45M
CELG
12
DELISTED
Celgene Corp
CELG
$9.72M 2.31%
108,651
+120
+0.1% +$10.6K
VFC icon
13
VF Corp
VFC
$6.68B
$9.24M 2.2%
105,047
+1,138
+1% +$97.1K
VRTX icon
14
Vertex Pharmaceuticals
VRTX
$121B
$8.15M 1.94%
42,305
+7,785
+23% +$1.39M
BABA icon
15
Alibaba
BABA
$269B
$7.54M 1.79%
45,769
-4,240
-8% -$750K
LMT icon
16
Lockheed Martin
LMT
$134B
$6.58M 1.56%
18,916
+275
+1% +$88.7K
ABBV icon
17
AbbVie
ABBV
$458B
$6.49M 1.54%
68,630
+769
+1% +$72.9K
LOW icon
18
Lowe's Companies
LOW
$116B
$6.19M 1.47%
53,921
+925
+2% +$96.4K
MSFT icon
19
Microsoft
MSFT
$2.84T
$6.16M 1.46%
53,635
+965
+2% +$105K
BAC.WS.A
20
DELISTED
Bank Of America Corporation Ws A
BAC.WS.A
$5.9M 1.4%
331,110
-38,050
-10% -$712K
CVX icon
21
Chevron
CVX
$388B
$5.74M 1.36%
46,518
+873
+2% +$106K
PG icon
22
Procter & Gamble
PG
$343B
$5.51M 1.31%
66,235
+1,150
+2% +$94.1K
MMM icon
23
3M
MMM
$89B
$5.38M 1.28%
30,315
+753
+3% +$130K
INTC icon
24
Intel
INTC
$464B
$5.19M 1.23%
109,115
+2,153
+2% +$105K
SLB icon
25
SLB Ltd
SLB
$78.4B
$5.18M 1.23%
84,989
-19,298
-19% -$1.24M

Similar funds

Biondo Investment Advisors's Q3 2018 Portfolio in Review

As of Q3 2018, Biondo Investment Advisors held 87 positions worth $421M, up 6.2% from $397M the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Biondo Investment Advisors withdrew a net $21.7M in Q3 2018, closing 7 positions and reducing 19 holdings. Its most notable exit was Meta Platforms (Facebook), an estimated $14M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 41% of assets, up from 35% a quarter earlier, followed by Financials and Technology.

Against the trend, Biondo Investment Advisors opened a new position in Intercept Pharmaceuticals, Inc. worth $3.84M.

  • Biondo Investment Advisors's largest Q3 2018 buy was Intercept Pharmaceuticals, Inc.: 30,395 shares worth $3.84M.
  • Biondo Investment Advisors added most to Regeneron Pharmaceuticals in Q3 2018, an estimated $3.45M increase.
  • Biondo Investment Advisors's biggest Q3 2018 reduction was Bristol-Myers Squibb, cutting an estimated $3.73M.
  • Biondo Investment Advisors fully exited Meta Platforms (Facebook) in Q3 2018, selling an estimated $14M.
  • Biondo Investment Advisors's ten largest holdings make up 54% of its $421M portfolio in Q3 2018.
  • Biondo Investment Advisors opened 6 new positions and closed 7 in Q3 2018.
  • Biondo Investment Advisors's portfolio value rose 6.2% quarter-over-quarter to $421M.

Based on Biondo Investment Advisors's 13F filing for Q3 2018, filed 7 Nov 2018.